QQQ   437.44 (-0.14%)
AAPL   182.81 (-0.85%)
MSFT   410.70 (-0.23%)
META   485.28 (-0.17%)
GOOGL   144.06 (-0.02%)
AMZN   174.98 (+0.23%)
TSLA   191.96 (-2.76%)
NVDA   791.93 (+0.83%)
NIO   5.43 (-7.18%)
AMD   176.72 (-2.83%)
BABA   75.99 (-0.17%)
T   16.81 (+1.33%)
F   12.15 (+0.25%)
MU   86.04 (+0.15%)
CGC   3.37 (+0.00%)
GE   153.46 (+1.18%)
DIS   107.86 (+0.20%)
AMC   4.45 (+0.68%)
PFE   27.82 (+0.98%)
PYPL   59.32 (+1.66%)
XOM   103.91 (-0.81%)
QQQ   437.44 (-0.14%)
AAPL   182.81 (-0.85%)
MSFT   410.70 (-0.23%)
META   485.28 (-0.17%)
GOOGL   144.06 (-0.02%)
AMZN   174.98 (+0.23%)
TSLA   191.96 (-2.76%)
NVDA   791.93 (+0.83%)
NIO   5.43 (-7.18%)
AMD   176.72 (-2.83%)
BABA   75.99 (-0.17%)
T   16.81 (+1.33%)
F   12.15 (+0.25%)
MU   86.04 (+0.15%)
CGC   3.37 (+0.00%)
GE   153.46 (+1.18%)
DIS   107.86 (+0.20%)
AMC   4.45 (+0.68%)
PFE   27.82 (+0.98%)
PYPL   59.32 (+1.66%)
XOM   103.91 (-0.81%)
QQQ   437.44 (-0.14%)
AAPL   182.81 (-0.85%)
MSFT   410.70 (-0.23%)
META   485.28 (-0.17%)
GOOGL   144.06 (-0.02%)
AMZN   174.98 (+0.23%)
TSLA   191.96 (-2.76%)
NVDA   791.93 (+0.83%)
NIO   5.43 (-7.18%)
AMD   176.72 (-2.83%)
BABA   75.99 (-0.17%)
T   16.81 (+1.33%)
F   12.15 (+0.25%)
MU   86.04 (+0.15%)
CGC   3.37 (+0.00%)
GE   153.46 (+1.18%)
DIS   107.86 (+0.20%)
AMC   4.45 (+0.68%)
PFE   27.82 (+0.98%)
PYPL   59.32 (+1.66%)
XOM   103.91 (-0.81%)
QQQ   437.44 (-0.14%)
AAPL   182.81 (-0.85%)
MSFT   410.70 (-0.23%)
META   485.28 (-0.17%)
GOOGL   144.06 (-0.02%)
AMZN   174.98 (+0.23%)
TSLA   191.96 (-2.76%)
NVDA   791.93 (+0.83%)
NIO   5.43 (-7.18%)
AMD   176.72 (-2.83%)
BABA   75.99 (-0.17%)
T   16.81 (+1.33%)
F   12.15 (+0.25%)
MU   86.04 (+0.15%)
CGC   3.37 (+0.00%)
GE   153.46 (+1.18%)
DIS   107.86 (+0.20%)
AMC   4.45 (+0.68%)
PFE   27.82 (+0.98%)
PYPL   59.32 (+1.66%)
XOM   103.91 (-0.81%)
NASDAQ:CDIO

Cardio Diagnostics (CDIO) Stock Price, News & Analysis

$1.82
+0.07 (+3.71%)
(As of 03:51 PM ET)
Today's Range
$1.73
$1.86
50-Day Range
$1.58
$3.06
52-Week Range
$0.17
$8.50
Volume
452,690 shs
Average Volume
1.61 million shs
Market Capitalization
$37.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

CDIO stock logo

About Cardio Diagnostics Stock (NASDAQ:CDIO)

Cardio Diagnostics Holdings, Inc., an artificial intelligence-powered precision cardiovascular medicine company, develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. The company was founded in 2017 and is headquartered in Chicago, Illinois.

CDIO Stock Price History

CDIO Stock News Headlines

How to profit from the new boom in gold
Gold just passed $2,000/oz and is set for a new bull run in 2024. Now a renowned precious metals expert is sharing his No. 1 way to play it for just $5. 
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Cardio Climbs on AMA Nod
See More Headlines
Receive CDIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardio Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
2/23/2024
Next Earnings (Estimated)
2/26/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostic substances
Sub-Industry
N/A
Current Symbol
NASDAQ:CDIO
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Net Income
$-4,660,000.00
Pretax Margin
-73,893.48%

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.45 per share

Miscellaneous

Free Float
14,378,000
Market Cap
$37.59 million
Optionable
Not Optionable
Beta
5.61
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Dr. Meeshanthini V. Dogan Ph.D. (Age 35)
    Co-Founder, CEO & Director
    Comp: $433.9k
  • Ms. Elisa Michael Luqman Esq. (Age 60)
    J.D., M.B.A., Chief Financial Officer
    Comp: $175.83k
  • Dr. Robert A. Philibert M.D. (Age 62)
    Ph.D., Co-Founder, Chief Medical Officer & Director
  • Mr. Timur Dogan Ph.D. (Age 36)
    Chief Technology Officer
  • Ms. Khullani Abdullahi J.D. (Age 40)
    Vice President of Revenue & Strategy














CDIO Stock Analysis - Frequently Asked Questions

Should I buy or sell Cardio Diagnostics stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cardio Diagnostics in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CDIO shares.
View CDIO analyst ratings
or view top-rated stocks.

How have CDIO shares performed in 2024?

Cardio Diagnostics' stock was trading at $2.49 at the beginning of the year. Since then, CDIO shares have decreased by 26.5% and is now trading at $1.8302.
View the best growth stocks for 2024 here
.

Are investors shorting Cardio Diagnostics?

Cardio Diagnostics saw a decrease in short interest in the month of January. As of January 31st, there was short interest totaling 757,500 shares, a decrease of 10.6% from the January 15th total of 847,000 shares. Based on an average daily volume of 9,520,000 shares, the short-interest ratio is currently 0.1 days. Currently, 4.5% of the shares of the stock are sold short.
View Cardio Diagnostics' Short Interest
.

When is Cardio Diagnostics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, February 26th 2024.
View our CDIO earnings forecast
.

Who are Cardio Diagnostics' major shareholders?

Cardio Diagnostics' stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (1.13%), Northern Trust Corp (0.22%) and Vontobel Holding Ltd. (0.06%). Insiders that own company stock include Meeshanthini Dogan and Robert Philibert.
View institutional ownership trends
.

How do I buy shares of Cardio Diagnostics?

Shares of CDIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CDIO) was last updated on 2/23/2024 by MarketBeat.com Staff